Shedir Pharma Srl Unipersonale
MIL:SHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shedir Pharma Srl Unipersonale
MIL:SHE
|
IT |
|
Fidia SpA
MIL:FDA
|
IT |
|
SAP SE
F:SAP
|
DE |
|
Eurocell PLC
LSE:ECEL
|
UK |
|
C
|
Ceres Power Holdings PLC
F:CFJ
|
UK |
|
V
|
Voltage Metals Corp
CNSX:VOLT
|
CA |
|
H
|
Hung Chou Fiber Ind Co Ltd
TWSE:1413
|
TW |
|
L
|
LIX Detergent JSC
VN:LIX
|
VN |
|
Itech Minerals Ltd
ASX:ITM
|
AU |
|
LBT Innovations Ltd
ASX:LBT
|
AU |
|
Telesis Bio Inc
NASDAQ:TBIO
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SHE's stock price target?
Not Available
SHE doesn't have any price targets made by Wall Street professionals.
What is Shedir Pharma Srl Unipersonale's Revenue forecast?
Projected CAGR
8%
For the last 5 years the
compound annual growth rate for
Shedir Pharma Srl Unipersonale's revenue is
5%.
The projected
CAGR
for the next 4 years is
8%.
What is Shedir Pharma Srl Unipersonale's Operating Income forecast?
Projected CAGR
8%
For the last 5 years the
compound annual growth rate for
Shedir Pharma Srl Unipersonale's operating income is
-2%.
The projected
CAGR
for the next 4 years is
8%.
What is Shedir Pharma Srl Unipersonale's Net Income forecast?
Projected CAGR
10%
For the last 5 years the
compound annual growth rate for
Shedir Pharma Srl Unipersonale's net income is
-3%.
The projected
CAGR
for the next 4 years is
10%.
